A major advance in cancer investigation is occurring with the use of VHH fragments to reactivate mutated p53. This crucial cancer inhibitor protein is frequently disabled in several forms of cancer, resulting https://bookmarkboom.com/story21911850/mini-antibodies-reactivate-the-p53-protein-a-promising-hope-for-malignant-management